Ontology highlight
ABSTRACT: Objective
To determine the frequency of germline and somatic pathogenic BRCA1 and BRCA2 variants in patients with high-grade serous ovarian cancer tested by next-generation sequencing (NGS), with the aim of defining the best strategy to be implemented in future routine testing.Design
National retrospective audit.Setting
The All Wales Medical Genomics Service (AWMGS).Population
Patients with high-grade serous ovarian/fallopian tube/peritoneal cancer referred by oncologists to the AWMGS between February 2015 and February 2021 for germline and/or tumour testing of the BRCA1 and BRCA2 genes by NGS.Methods
Analysis of NGS data from germline and/or tumour testing.Main outcome measures
Frequency of BRCA1 and BRCA2 pathogenic variants.Results
SUBMITTER: Frugtniet B
PROVIDER: S-EPMC9298909 | biostudies-literature | 2022 Feb
REPOSITORIES: biostudies-literature